$BLGO BioLargo’s First Quarterly Report of 2022 Highlights: Record Company-wide Revenues, Subsidiaries Achieving and Approaching Profitability, and Progress of Key Growth Catalysts #BLGO @biolargo
https://stockdaymedia.com/biotech-corner/biol...ysts-blgo/